NMDA receptor antibody in teratoma-related opsoclonus-myoclonus syndrome
- 1 December 2018
- journal article
- research article
- Published by Elsevier BV in Journal of Clinical Neuroscience
- Vol. 58, 203-204
- https://doi.org/10.1016/j.jocn.2018.10.011
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Opsoclonus-myoclonus syndrome during rituximab treatment for autoimmune autonomic ganglionopathyNeurology Neuroimmunology & Neuroinflammation, 2017
- Human cerebrospinal fluid monoclonalN-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesisBrain, 2016
- New Findings in Adult Opsoclonus-Myoclonus SyndromeJAMA Neurology, 2016
- Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface AntibodiesJAMA Neurology, 2016
- Pediatric Opsoclonus-Myoclonus-Ataxia Syndrome Associated With Anti-N-methyl-D-aspartate Receptor EncephalitisPediatric Neurology, 2015
- A novel treatment‐responsive encephalitis with frequent opsoclonus and teratomaAnnals of Neurology, 2013
- N-methyl-D-aspartate Receptor Autoimmune Encephalitis Presenting With Opsoclonus-MyoclonusArchives of Neurology, 2011
- Opsoclonus-Myoclonus Syndrome in Anti-N-Methyl-D-Aspartate Receptor EncephalitisArchives of Neurology, 2010
- Opsoclonus in three dimensions: oculographic, neuropathologic and modelling correlatesJournal of the Neurological Sciences, 2001